NYSEAMERICAN:VTAK

Catheter Precision (VTAK) Stock Price, News & Analysis

Catheter Precision logo
$0.15 0.00 (0.00%)
As of 10/9/2026

About Catheter Precision Stock (NYSEAMERICAN:VTAK)

Key Stats

Today's Range
$0.15
▼
$1.51
50-Day Range
$0.15
▼
$1.75
52-Week Range
$0.13
▼
$3.20
Volume
N/A
Average Volume
1.54 million shs
Market Capitalization
$2.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Catheter Precision is a medical technology company focused on products for electrophysiology, the specialty concerned with diagnosing and treating abnormal heart rhythms. Its products are designed to support clinicians during procedures involving cardiac arrhythmias.

The company’s VIVO system uses patient-specific imaging and electrical data to create a three-dimensional view of the heart and help clinicians locate the source of ventricular arrhythmias before ablation procedures. Catheter Precision also offers LockeT, a device intended to assist with closure of femoral venous access sites after procedures.

Catheter Precision’s product portfolio reflects its focus on tools for planning and supporting electrophysiology procedures. Its shares trade on the NYSE American under the symbol VTAK.

AI Generated. May Contain Errors.

Receive VTAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Catheter Precision and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VTAK Stock News Headlines

What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
See More Headlines

VTAK Stock Analysis - Frequently Asked Questions

Catheter Precision's stock was trading at $18.30 at the start of the year. Since then, VTAK stock has decreased by 99.2% and is now trading at $0.1510.

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) announced its earnings results on Monday, November, 16th. The company reported ($8.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($13.30) by $5.14. The company earned $1.84 million during the quarter, compared to the consensus estimate of $2.80 million. Catheter Precision had a negative trailing twelve-month return on equity of 37.53% and a negative net margin of 656.03%.

Shares of Catheter Precision reverse split on the morning of Monday, August 18th 2025.The 1-19 reverse split was announced on Friday, August 15th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Company Calendar

Last Earnings
11/16/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSEAMERICAN:VTAK
CIK
1716621
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.18 million
Net Margins
-656.03%
Pretax Margin
-721.20%
Return on Equity
-37.53%
Return on Assets
-13.05%

Debt

Debt-to-Equity Ratio
0.19
Current Ratio
0.19
Quick Ratio
0.18

Sales & Book Value

Annual Sales
$820 thousand
Price / Sales
2.65
Cash Flow
$5.03 per share
Price / Cash Flow
0.03
Book Value
$3.82 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
14,390,000
Free Float
13,544,000
Market Cap
$2.17 million
Optionable
N/A
Beta
-0.99
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NYSEAMERICAN:VTAK) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners